Acquisition by Steven Binder of 67536 shares of MannKind Corp at 1.47 subject to Rule 16b-3
MNKD Stock | USD 6.61 0.06 0.90% |
About 54% of MannKind Corp's investor base is interested to short. The analysis of the overall investor sentiment regarding MannKind Corp suggests that many traders are impartial. The current market sentiment, together with MannKind Corp's historical and current headlines, can help investors time the market. In addition, many technical investors use MannKind Corp stock news signals to limit their universe of possible portfolio assets.
MannKind |
Filed transaction by MannKind Corp Director. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
MannKind Corp's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the MannKind Corp's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
MannKind Corp Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards MannKind Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
MannKind Corp Fundamental Analysis
We analyze MannKind Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MannKind Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MannKind Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
MannKind Corp is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
MannKind Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MannKind Corp stock to make a market-neutral strategy. Peer analysis of MannKind Corp could also be used in its relative valuation, which is a method of valuing MannKind Corp by comparing valuation metrics with similar companies.
Peers
MannKind Corp Related Equities
ELEV | Elevation Oncology | 15.38 | ||||
ADAP | Adaptimmune Therapeutics | 3.23 | ||||
LQDA | Liquidia Technologies | 1.77 | ||||
PCVX | Vaxcyte | 0.69 | ||||
KNSA | Kiniksa Pharmaceuticals | 0.42 | ||||
UTHR | United Therapeutics | 0.06 | ||||
TECH | Bio Techne | 0.40 | ||||
DAWN | Day One | 0.45 | ||||
SGMO | Sangamo Therapeutics | 0.51 | ||||
BMRN | Biomarin Pharmaceutical | 0.69 | ||||
INKT | Mink Therapeutics | 1.52 | ||||
VSTM | Verastem | 1.80 | ||||
IMMP | Immutep | 2.75 | ||||
LRMR | Larimar Therapeutics | 2.81 | ||||
AFMD | Affimed NV | 2.93 | ||||
KTTA | Pasithea Therapeutics | 6.46 | ||||
LEGN | Legend Biotech | 8.96 | ||||
SABS | SAB Biotherapeutics | 9.41 |
Complementary Tools for MannKind Stock analysis
When running MannKind Corp's price analysis, check to measure MannKind Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MannKind Corp is operating at the current time. Most of MannKind Corp's value examination focuses on studying past and present price action to predict the probability of MannKind Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MannKind Corp's price. Additionally, you may evaluate how the addition of MannKind Corp to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |